The only update for patients with stage IV NSCLC without driver alterations is that patients who have HER2-overexpressing (IHC 3+) disease and good performance status can receive trastuzumab ...

Doctors stage non-small cell lung cancer (NSCLC) according to how far it has progressed. Stages range from occult (or hidden) cancer to stage 4 cancer, in which multiple organs may be affected.

New research delves into the DNA details and chromatin structures that may predict prognosis in early-stage lung ...

Research assessing the nutritional status and impact of interventions for patients with lung cancer found that most exhibit ...

For patients with metastatic non–small cell lung cancer (NSCLC), subcutaneous (SC ... enrolled 377 patients with newly diagnosed stage IV NSCLC without sensitizing genetic mutations.

Survival rates for metastatic lung cancer Researchers base cancer survival rates on the type of cancer, the subtype of cancer, and the stage at diagnosis ... are about 1.4% each year from 2019 ...

Despite the high incidence of brain metastasis after resection of non-small cell lung cancer (NSCLC), the National Comprehensive Cancer Network guidelines do not recommend central nervous system (CNS) ...

Treatment with CAN-2409, an off-the-shelf immunotherapy, elicited responses among patients with pretreated stage 3/4 ...

The CDC says in the U.S. about 10 to 20 percent of lung cancers are found in non-smokers. That also includes people smoking ...